View Older Stories View More Recent Stories
-
Notable Analyst Rating Changes 2/11: (TWX) (BDX) (LVLT) Upgraded; (V) (SEMI) (ARMH) Downgraded
-
Notable Analyst Rating Changes 2/5: (GS) (ALL) (ABT) Upgraded; (LNKD) (KSS) (LINE) Downgraded
-
Tiger Management Shows New Stakes in Lumber Liquidators (LL), Sony (SNE), (more...)
-
Cooperman's Omega Advisors Shows News Stakes in GM (GM), Dow (DOW), Mobileye (MBLY); Sells Apple (AAPL)
-
Three Small Cap Biotech Stocks Added to Citi's Most Preferred List (ATRA) (NVAX) (PBYI)
-
Cooperman's Omega Advisors Adds to eBay (EBAY), Groupon (GRPN); Lowers Apple (AAPL); Liquidates Alibaba (BABA) (more...)
-
Notable Analyst Rating Changes 1/6: (ORCL) (FDX) (LOCO) Upgraded; (INFN) (GE) (KORS) Downgraded
-
Streetinsider.com's Hot Lunchtime Reads 12/11: (PEP) (SPLS) (PCAR) (GILD)
-
UPDATE: Tiger Management 13F Shows New Stakes in Alibaba (BABA) CoStar Group (CSGP) eBay Inc. (EBAY) Harman (HAR) and More
-
Heebner's Capital Growth Cuts Micron (MU), Ford (F), Adds BofA (BAC) in Q3
-
Puma Biotechnology (PBYI) Adds to Gains as M&A Speculation Heats Up
-
Loeb's Third Point LLC Shows news Stakes in Actavis (ACT), American Airlines (AAL), Citrix (CRX), Verizon (VZ); Liquidates (YHOO) (AAPL) (BBRY)
-
Griffin's Blue Ridge Capital Shows New Stakes in Allegion (ALLE), Castlight Health (CSLT), Myriad Genetics (MYGN), Walgreen (WAG) (more...)
-
Blue Ridge Capital Enters Apple (AAPL), Twitter (TWTR) (more...)
-
Gilead Sciences (GILD) Target Lifted to $96 at Citi
-
Griffin's Blue Ridge Capital Enters 3D Systems (DDD), Tesla (TSLA), BlackBerry (BBRY)
-
Griffin's Blue Ridge Enters Avis (CAR), LinkedIn (LNKD); Ups Citi (C), Cuts Gilead (GILD) (more...)
-
Notable Analyst Rating Changes 06/13: (BBRY) (ROST) (GILD) Upgraded; (MPW) (SWY) (PPO) Downgraded
-
Griffin's Blue Ridge Capital Enters CBS (CBS), Citigroup (C), Netflix (NFLX); Exits Apple (AAPL)
-
StreetInsider.com Pre-Open Movers 02/05: (OPXA) (PLX) (VMED) Higher; (HEB) (YUM) (JCP) Lower (more...)
-
StreetInsider.com Pre-Open Movers 11/12: (TIE) (JEF) (GILD) Higher; (CLVS) (STSI) (GRMN) Lower (more...)
-
Notable Analyst Rating Changes 10/01: (MDRX) (GILD) (CWTR) Upgraded; (MSFT) (PHM) (ALU) Downgraded
-
Griffin's Blue Ridge Capital Shows New Stakes in MLM, KORS, TRIP; Raises AAPL, C, JPM
-
Notable Analyst Rating Changes 02/21: (DANG) (FRO) (BRCM) Upgraded; (UA) (GILD) (CTRP) Downgraded
-
Notable Analyst Rating Changes 02/10: (COP) (JDSU) (ATVI) Upgraded; (ORLY) (XCO) (AKS) Downgraded
-
Pre-Open Movers 2/3: (ZOLG) (GILD) (URBN) Higher; (THQI) (EW) (APKT) Lower (more...)
-
Pre-Open Movers 11/28: (CMC) (C) (AMZN) Higher; (GOLD) (GEF) Lower (more...)
-
Shares of Gilead Sciences (GILD) Gain Back Majority of Acquisition Dip
-
Citi Upgrades Gilead Sciences (GILD) to Buy, Raises Target to $49
-
Notable Analyst Rating Changes 06/29: (C) (X) (GILD) Upgraded; (SHAW) (ARMH) (ASML) Downgraded
-
Ainslie's Maverick Capital Shows New Stakes In Goldman Sachs (GS) and Wells Fargo (WFC), Also Like Solar (TSL) (YGE)
-
Clough Capital Buys More Citigroup (C), Opens Petrohawk Energy (HK) Position and Lowers Cisco (CSCO)
-
George Soros' Hedge Fund Slashes Stake In Gold ETF (GLD), Raises Stake in Citi (C) and AT&T (T)
-
Notable Analyst Rating Changes 11/16: CAT, CREE, S, BRCD Upgraded; NLST, BUCY, PWRD, JOYG Downgraded
-
Notable Analyst Rating Changes 07/21: GS, WFR, FRO, SQNM Upgraded; YHOO, GILD, STX, HBHC Downgraded
-
UPDATE - Citi Downgrades Gilead Sciences (GILD) to Hold; HIV Trends Decelerating in U.S. - No Near-Term Catalysts
-
Citi Downgrades Gilead Sciences (GILD) to Hold
-
Goldman Sachs' Hedge Fund VIP List (CIT, CF, ACL, GILD, more...)
-
Citi Maintains a 'Buy' on Gilead Sciences (GILD); $5B Buyback Encouraging; Stock Is Undervalued Relative to Cash Flow
-
Notable Analyst Rating Changes 02/19: ADBE, SCHW, WBMD, SFI Upgraded; FSLR, ELGX, WIN, AAP Downgraded
-
Active equity option families in first 30 minutes: C YHOO GILD F
-
Notable Analyst Rating Changes 9/2: TXT, CBE, SI, PAY, BBD Upgraded; ROK, GIS, HOLX, DHI, RYL, NVAX Downgraded
-
David Moenning’s Daily State of the Markets: 7/22
-
David Moenning's Daily State of the Markets: 7/10
-
Citi Maintains a 'Buy' on Gilead Sciences (GILD); Cautiously Optimistic
-
Spring Brings 'Green Shoots' For Stocks
-
Top 10 News Items 3/9-3/13: Stock Stage 4-Day Win Streak; Bank CEOs Make Upbeat Comments (C, JPM, BAC); GE (GE) Gets Rating Cut
-
Morning Movers 3/12: CV Therapeutics (CVTX) Surges On Buyout, GE (GE) Up On Rating Cut/Stable Outlook
-
Citi Maintains a 'Buy' on Gilead Sciences (GILD); Comments on Acquisition Offer of CVTX
-
David Moenning's Daily State of the Markets: 1/28

